PL354295A1 - Kompozycja farmaceutyczna - Google Patents
Kompozycja farmaceutycznaInfo
- Publication number
- PL354295A1 PL354295A1 PL00354295A PL35429500A PL354295A1 PL 354295 A1 PL354295 A1 PL 354295A1 PL 00354295 A PL00354295 A PL 00354295A PL 35429500 A PL35429500 A PL 35429500A PL 354295 A1 PL354295 A1 PL 354295A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical composition
- insulin sensitizer
- sensitizer
- insulin
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25044399 | 1999-09-03 | ||
| JP2000056021 | 2000-02-28 | ||
| PCT/JP2000/005951 WO2001017513A2 (en) | 1999-09-03 | 2000-09-01 | Pharmaceutical composition comprising an insulin sensitizer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL354295A1 true PL354295A1 (pl) | 2004-01-12 |
Family
ID=26539777
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL00354295A PL354295A1 (pl) | 1999-09-03 | 2000-09-01 | Kompozycja farmaceutyczna |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1212090A2 (pl) |
| KR (1) | KR20020063555A (pl) |
| CN (1) | CN1372476A (pl) |
| AR (1) | AR031674A1 (pl) |
| AU (1) | AU6868000A (pl) |
| CA (1) | CA2383946A1 (pl) |
| CO (1) | CO5180632A1 (pl) |
| HK (1) | HK1044711A1 (pl) |
| HU (1) | HUP0203285A3 (pl) |
| NO (1) | NO20021036L (pl) |
| PE (1) | PE20010580A1 (pl) |
| PL (1) | PL354295A1 (pl) |
| RU (1) | RU2002108346A (pl) |
| WO (1) | WO2001017513A2 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1695716A2 (en) | 2000-12-26 | 2006-08-30 | Sankyo Company, Limited | Medicinal compositions containing diuretics and insulin sensitizers |
| JP4590159B2 (ja) | 2001-04-04 | 2010-12-01 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法 |
| WO2002080935A1 (en) | 2001-04-04 | 2002-10-17 | Ortho Mcneil Pharmaceutical, Inc. | Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| FR2838968A1 (fr) * | 2002-04-30 | 2003-10-31 | Lipha | Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete |
| AU2003242245A1 (en) | 2002-06-12 | 2003-12-31 | Sumitomo Pharmaceuticals Co., Ltd. | Indole, indazole, and benzazole derivative |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990005721A1 (en) * | 1988-11-14 | 1990-05-31 | The Upjohn Company | Alpha-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents |
| DK0514452T4 (da) * | 1990-02-09 | 2000-09-18 | Upjohn Co | Anvendelse af insulin-sensibiliserende midler til behandling af hypertension |
| SK281865B6 (sk) * | 1994-11-29 | 2001-08-06 | Dainippon Pharmaceutical Co., Ltd. | Indolový derivát a jeho optický izomér, spôsob jeho prípravy a farmaceutický prostriedok |
-
2000
- 2000-08-29 PE PE2000000887A patent/PE20010580A1/es not_active Application Discontinuation
- 2000-08-30 AR ARP000104514A patent/AR031674A1/es not_active Application Discontinuation
- 2000-09-01 WO PCT/JP2000/005951 patent/WO2001017513A2/en not_active Application Discontinuation
- 2000-09-01 KR KR1020027002851A patent/KR20020063555A/ko not_active Application Discontinuation
- 2000-09-01 CN CN00812420A patent/CN1372476A/zh active Pending
- 2000-09-01 HU HU0203285A patent/HUP0203285A3/hu unknown
- 2000-09-01 AU AU68680/00A patent/AU6868000A/en not_active Abandoned
- 2000-09-01 CA CA002383946A patent/CA2383946A1/en not_active Abandoned
- 2000-09-01 EP EP00956872A patent/EP1212090A2/en not_active Withdrawn
- 2000-09-01 RU RU2002108346/14A patent/RU2002108346A/ru not_active Application Discontinuation
- 2000-09-01 PL PL00354295A patent/PL354295A1/pl not_active Application Discontinuation
- 2000-09-01 CO CO00065981A patent/CO5180632A1/es not_active Application Discontinuation
-
2002
- 2002-03-01 NO NO20021036A patent/NO20021036L/no not_active Application Discontinuation
- 2002-08-15 HK HK02105969.4A patent/HK1044711A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0203285A2 (hu) | 2003-01-28 |
| CN1372476A (zh) | 2002-10-02 |
| KR20020063555A (ko) | 2002-08-03 |
| CA2383946A1 (en) | 2001-03-15 |
| HK1044711A1 (zh) | 2002-11-01 |
| EP1212090A2 (en) | 2002-06-12 |
| CO5180632A1 (es) | 2002-07-30 |
| NO20021036L (no) | 2002-04-26 |
| WO2001017513A3 (en) | 2001-09-20 |
| AU6868000A (en) | 2001-04-10 |
| AR031674A1 (es) | 2003-10-01 |
| HUP0203285A3 (en) | 2003-02-28 |
| NO20021036D0 (no) | 2002-03-01 |
| PE20010580A1 (es) | 2001-05-25 |
| WO2001017513A2 (en) | 2001-03-15 |
| RU2002108346A (ru) | 2003-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL351387A1 (en) | Pharmaceutical composition | |
| IL149224A0 (en) | Hydrogen-driven drug dosage form | |
| IL183972A0 (en) | Pharmaceutical composition for modified release insulin sensitiser | |
| ZA200000857B (en) | Pharmaceutical composition. | |
| EG23858A (en) | Drug combination | |
| HUP0000137A3 (en) | Controller-release pharmaceutical composition containing anangetics | |
| IL145632A0 (en) | Pharmaceutical compounds | |
| GB9916434D0 (en) | Pharmaceutical compounds | |
| GB9914255D0 (en) | Pharmaceutical compounds | |
| HK1044711A1 (zh) | 包含胰島素敏化劑的藥物組合物 | |
| GB9903784D0 (en) | Pharmaceutical compounds | |
| GB9909154D0 (en) | Pharmaceutical formulation | |
| GB2373499B (en) | Pharmaceutical compounds | |
| GB9930160D0 (en) | Drug delivery | |
| GB9916210D0 (en) | Pharmaceutical composition | |
| GB9916413D0 (en) | Pharmaceutical composition | |
| HU9900587D0 (en) | New pharmaceutical composition | |
| GB9910671D0 (en) | Improved pharmaceutical composition | |
| GB9904304D0 (en) | Drug delivery | |
| GB9902593D0 (en) | Drug combinations | |
| GB9921064D0 (en) | Drug combination | |
| AUPP969899A0 (en) | Pharmaceutical composition | |
| AUPQ386599A0 (en) | Pharmaceutical composition | |
| GB9926434D0 (en) | Pharmaceutical | |
| GB9909073D0 (en) | Novel pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |